logo
[breadcrumb_custom]

Tag: GERN Shares

TOST Stock
Industry

Geron Corp. (GERN) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Geron Corp.’s current trading price is -8.89% away from its 52-week high, while its distance from the 52-week low is 125.00%. The stock’s price range for this time frame has been between $1.64 and $4.05. The trading volume of the company’s shares in the Healthcare reached around 8.23 million for the day, which was evidently lower than the average daily volume of 12.56 million over the last three months. Geron Corp.’s stock has seen a smooth market performance. The

Finance

GERN’s Market Whiplash: 72.51% YTD Rise, 93.62% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 72.51% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 92.59%. Over the past 30 days, the price of GERN has fallen by 93.62%. And in the last five days, it has surged by 9.64%. Geron Corp. experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $3.79 on 04/12/24, while the

Industry

Geron Corp.’s Mixed Bag: Up 79.01% in 6 Months, Up 54.29% in 30 Days

Geron Corp. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.73 on 06/09/23, while the lowest price during the same period was $1.64 on 03/13/24. 52-week price history of GERN Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Geron Corp.’s current trading price is -13.25% away from its 52-week high, while its distance from the 52-week low is 97.56%. The stock’s price range for this period

VIPS stock
Industry

Geron Corp. (GERN) Stock: A Year of Highs and Lows

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Geron Corp.’s current trading price is -17.00% away from its 52-week high, while its distance from the 52-week low is 89.02%. The stock’s price range during this period has varied between $1.64 and $3.73. The company, active in the Healthcare sector, saw a trading volume of around 9.3 million for the day, considerably lower average daily volume of 11.26 million observed over the last three months. Geron Corp.’s stock has had a calm market performance.

CROX
Finance

Geron Corp. (GERN) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Geron Corp.’s current trading price is -11.65% away from its 52-week high, while its distance from the 52-week low is 101.22%. The stock’s price range over this period has fluctuated between $1.64 and $3.73. The company, operating within the financial sector, had a trading volume of approximately 13.01 million for the day, which was noticeably higher than the average daily share volume of 11.11 million over the last 3 months. In terms of market performance, Geron Corp.

Finance

GERN’s Stock Dilemma: Geron Corp.’s Market Performance and Outlook

In terms of market performance, Geron Corp. had a somewhat regular. The highest value for the stock in the past year was $3.73 on 06/09/23, while the lowest value was $1.64 on 03/13/24. 52-week price history of GERN Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Geron Corp.’s current trading price is -11.38% away from its 52-week high, while its distance from the 52-week low is 101.83%. The stock’s price range for this period has remained between $1.64 and $3.73. The

Finance

Company’s Banking Stock: Dissecting a 60.77% Quarterly Revenue Decline Amid Growth

Geron Corp.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $3.73 on 06/09/23, with the lowest value being $1.64 on 03/13/24. 52-week price history of GERN Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Geron Corp.’s current trading price is -10.04% away from its 52-week high, while its distance from the 52-week low is 104.88%. The stock’s price range for this period has remained between $1.64 and $3.73. The Healthcare sector company’s shares

Industry

GERN’s Stock Market Pendulum: Swinging Between Gains and Losses

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 7.35% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -7.55%. Over the past 30 days, the price of GERN has fallen by 18.59%. And in the last five days, it has surged by 8.89%. The market performance of Geron Corp. has been somewhat unstable. Over the past year, the company’s stock

Stock

Anchoring Your Portfolio: Is GERN Stock a Safe Harbor?

Geron Corp. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.73 on 06/09/23 and the lowest value was $1.68 on 11/13/23. 52-week price history of GERN Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Geron Corp.’s current trading price is -39.49% away from its 52-week high, while its distance from the 52-week low is 34.52%. The stock’s price range during the 52-week period has remained between $1.68 and $3.73. In the Healthcare sector, the company’s